HCP
NVO

Hexagon Capital Partners’s Novo Nordisk NVO Stock Holding History

Hexagon Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Buy
9,784
+2,442
+33% +$105K 0.07% 146
2026
Q1 		$270K Buy
+7,342
New +$348K 0.04% 198
2025
Q2 		– Sell
-5,865
Closed -$407K – 1165
2025
Q1 		$407K Sell
5,865
-729
-11% -$60.2K 0.08% 122
2024
Q4 		$567K Buy
6,594
+704
+12% +$76.1K 0.1% 95
2024
Q3 		$701K Sell
5,890
-55
-0.9% -$7.33K 0.14% 73
2024
Q2 		$849K Buy
5,945
+110
+2% +$14.6K 0.18% 58
2024
Q1 		$749K Buy
5,835
+230
+4% +$27.4K 0.17% 66
2023
Q4 		$580K Buy
5,605
+1,059
+23% +$105K 0.14% 81
2023
Q3 		$413K Buy
4,546
+158
+4% +$13.9K 0.11% 91
2023
Q2 		$355K Sell
4,388
-32
-0.7% -$2.61K 0.09% 102
2023
Q1 		$352K Buy
4,420
+54
+1% +$3.83K 0.1% 104
2022
Q4 		$295K Sell
4,366
-158
-3% -$9.26K 0.09% 114
2022
Q3 		$225K Buy
4,524
+698
+18% +$37.4K 0.07% 138
2022
Q2 		$213K Buy
3,826
+584
+18% +$32.4K 0.06% 164
2022
Q1 		$180K Buy
3,242
+32
+1% +$1.64K 0.05% 190
2021
Q4 		$180K Hold
3,210
– – 0.05% 191
2021
Q3 		$154K Buy
3,210
+58
+2% +$2.8K 0.04% 188
2021
Q2 		$132K Hold
3,152
– – 0.04% 205
2021
Q1 		$106K Buy
3,152
+84
+3% +$2.99K 0.03% 220
2020
Q4 		$107K Sell
3,068
-40
-1% -$1.38K 0.03% 180
2020
Q3 		$101K Buy
+3,108
New +$104K 0.03% 175

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hexagon Capital Partners's NVO Position: Q2 2026 in Review

Hexagon Capital Partners increased its Novo Nordisk (NVO) stake by 33% in Q2 2026, buying an estimated $105K and bringing the position to 9,784 shares worth $469K. The position accounts for 0.07% of the portfolio, ranked #146.

Hexagon Capital Partners first reported a position in NVO in Q3 2020 and has held it in 21 quarters since. The position peaked at $849K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Hexagon Capital Partners held 9,784 shares of Novo Nordisk worth $469K as of Q2 2026.
  • Hexagon Capital Partners bought 2,442 Novo Nordisk shares in Q2 2026, an estimated $105K.
  • Novo Nordisk made up 0.07% of Hexagon Capital Partners's portfolio in Q2 2026, its #146 holding.
  • Hexagon Capital Partners first reported a position in Novo Nordisk in Q3 2020 and has held it in 21 quarters since.
  • Hexagon Capital Partners's Novo Nordisk position peaked at $849K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hexagon Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.